DelveInsight’s Drug Active Pharmaceutical Ingredient Reports – 2015

New Delhi, India, July 10, 2015 --(PR.com)-- DelveInsight's report gives the clear idea, related to the drugs, on the United States Drug Master File (USDMF) and Europe DMF filed by countries worldwide. The Report also gives insight to major API Manufactures in India and China who are driving the API market. DelveInsight's report also highlights the patent, patent exclusivity information and competitive landscape. The report also provides global sales forecast up to 2016. It includes marketed data of drugs on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification.

The Drug API insight Report will help the Asian (India and China) API manufacturers to gain competitive edge in global API market. The Drug API Reports give opportunities to Generic and API industry to add new drugs into their portfolio by analyzing the major factors that drives and those that act as constraints to the global market.

DelveInsight is offering the Report at a price of USD 500 as a single user license, USD 1,000 as a site license and USD 1,500 as a Global/Enterprise License.

For more information on API insight Reports, email at info@delveinsight.com

About Us:
DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver critical information to leading decision makers.We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.